DUSTIN GROSSHEIM: Open Payments
NPI 1598395709 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $867 · 2025 $252
Food & beverage: $175Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $77 |
| ABBVIE INC. | 2 | $47 |
| PFIZER INC. | 2 | $33 |
| GENZYME CORPORATION | 1 | $31 |
| VIVUS LLC | 1 | $24 |
| Ardelyx, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: TREMFYA, XELJANZ, DUPIXENT, SKYRIZI, QSYMIA, IBSRELA, RINVOQ, XIFAXAN.
Industry payments across CA — which companies pay providers there.
